Triazole compounds that modualte HSP90 activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9120745
SERIAL NO

14285834

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTA PHARMACEUTICALS CORPLEXINGTON MA 02421

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chimmanamada, Dinesh U Arlington, US 52 975
Kowalczyk-Przewloka, Teresa Tewksbury, US 15 89
Koya, Keizo Chestnut Hill, US 100 1179
Li, Hao Brookline, US 560 4472
Sun, Lijun Harvard, US 223 2689
Ying, Weiwen Lexington, US 100 1571
Zhang, Shijie Nashua, US 66 1272

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00